Biopharmaceutical, COVID-19

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded $8.9 million for high-impact biopharmaceutical manufacturing projects to support the nation’s response to the COVID-19 pandemic. Authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act signed by President Donald Trump in March...

Biopharmaceutical, COVID-19

The last few weeks have undoubtedly been a paradigm shift for many in our community. Whether an educator, parent, student, scientist, or executive - every single member of the NIIMBL community is adapting quickly to new norms in our business, academic, and personal lives in response to the current coronavirus pandemic. As the world is waiting for...